Mild symptomatic SARS-CoV-2 infection and cognitive decline

Takeaway

  • There is evidence of cognitive decline among adults aged over 40 years following mild symptomatic coronavirus-19 (COVID-19) infection.

Why this matters

  • Studies report COVID-19 related neurological complications closely following severe illness; however, there is little to no published information on delayed complications of moderate-to-mild infection in any population.

  • The occurrence of cognitive decline in mild COVID-19 adds to growing knowledge of both short- and long-term effects of this virus; and highlights the importance of thorough investigation of patients with a COVID-19 history for further clarification of its sequelae.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.